nodes	percent_of_prediction	percent_of_DWPC	metapath
Glisoxepide—Sulfamethoxazole—NAT2—head and neck cancer	0.523	0.523	CrCbGaD
Glisoxepide—Gliclazide—VEGFA—head and neck cancer	0.477	0.477	CrCbGaD
